Nkarta (NKTX) Current Leases (2019 - 2026)
Nkarta's quarterly Current Leases came in at $7.1 million in Q1 2026, up 19.01% year-on-year from $6.0 million in Q1 2025, and up 2.79% quarter-over-quarter from $6.9 million in Q4 2025.
Nkarta has reported Current Leases for 8 years, with the latest figure at $7.1 million in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 19.01% year-over-year to $7.1 million; the trailing twelve-month figure through Mar 2026 stood at $7.1 million (up 19.01% YoY), and the FY2025 full-year result was $6.9 million, up 13.87% from the prior year.
- Current Leases for Q1 2026 stood at $7.1 million, up from $6.9 million in the prior quarter.
- The five-year high for Current Leases was $7.1 million in Q1 2026, with the low at $2.5 million in Q1 2022.
- Average Current Leases over 5 years is $5.7 million, with a median of $6.0 million recorded in 2023.
- Year-over-year, Current Leases surged 129.62% in 2023 and decreased 8.56% in 2024.
- Tracing NKTX's Current Leases over 5 years: stood at $4.2 million in 2022, then jumped by 42.83% to $6.1 million in 2023, then retreated by 0.31% to $6.0 million in 2024, then increased by 13.87% to $6.9 million in 2025, then gained by 2.79% to $7.1 million in 2026.
- The last three Current Leases figures came in at $7.1 million (Q1 2026), $6.9 million (Q4 2025), and $6.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Nkarta | 232.80 Mn | 232.80 Mn | - | 7.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.08 Mn |
| Dec 31, 2025 | 6.89 Mn |
| Sep 30, 2025 | 6.37 Mn |
| Jun 30, 2025 | 6.91 Mn |
| Mar 31, 2025 | 5.95 Mn |
| Dec 31, 2024 | 6.05 Mn |
| Sep 30, 2024 | 6.76 Mn |
| Jun 30, 2024 | 5.53 Mn |
| Mar 31, 2024 | 6.08 Mn |
| Dec 31, 2023 | 6.07 Mn |
| Sep 30, 2023 | 6.06 Mn |
| Jun 30, 2023 | 6.05 Mn |
| Mar 31, 2023 | 5.75 Mn |
| Dec 31, 2022 | 4.25 Mn |
| Sep 30, 2022 | 5.36 Mn |
| Jun 30, 2022 | 3.07 Mn |
| Mar 31, 2022 | 2.51 Mn |
| Dec 31, 2021 | 2.48 Mn |
| Sep 30, 2021 | 2.46 Mn |
| Jun 30, 2021 | 2.29 Mn |
| Mar 31, 2021 | 2.15 Mn |
| Dec 31, 2020 | 1.40 Mn |
| Sep 30, 2020 | 1.48 Mn |
| Jun 30, 2020 | 1.52 Mn |
| Dec 31, 2019 | 1.52 Mn |